The Quarterly Provider Update provides a listing of Agency regulations and meeting notices. Non-regulatory changes to the Medicare and Medicaid programs, consisting of manual instructions, are also included in this listing.
R590CP | Aprepitant for Chemotherapy-Induced Emesis | 07/05/2005 | 04/01/2005 |
R588CP | Coverage of Colorectal Anti-Cancer Drugs Included in Clinical Trials | 07/05/2005 | 04/01/2005 |
R583CP | Access Process for HIPAA 270/271 (Extranet Only) | 08/22/2005 | 04/01/2005 |
R576CP | Correction to Chapter 17, Section 80.2.3, MSN/ANSI X12N Denial Messages for Anti-Emetic Drugs | 07/01/2005 | 04/01/2005 |
R565CP | Access Process for HIPAA 270/271 (Extranet Only) | 08/22/2005 | 04/01/2005 |
R561CP | New April 2005 Quarterly ASP Medicare Part B Drug Pricing File and Revisions to January 2005 Quarterly ASP Medicare Part B Drug Pricing File | 07/05/2005 | 04/01/2005 |
R541CP | Correction to the use of Group Codes for The Enforcement of Mandatory Electronic Submission of Medicare Claims | 07/05/2005 | 04/01/2005 |
R532CP | Abarelix for the Treatment of Prostate Cancer | 05/25/2005 | 04/01/2005 |
R531CP | Percutaneous Transluminal Angioplasty (PTA) | 07/05/2005 | 04/01/2005 |
R527CP | New Coding for FDG PET Scans and Billing Requirements for Specific Indications of Cervical Cancer | 04/18/2005 | 04/01/2005 |